Remove Immune Response Remove Science Remove Vaccine
article thumbnail

One shot to stop HIV: MIT's bold vaccine breakthrough

Science Daily: Pharmacology News

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly a month, encouraging the body to produce a vast array of antibodies.

Vaccine 234
article thumbnail

New mRNA vaccine created to prevent and treat C. difficile

Science Daily: Pharmacology News

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile vaccine was found to protect against C. difficile vaccine was found to protect against C. difficile or C. In animal models, this first mRNA-LNP C.

Vaccine 304
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Left or right arm? New research reveals why vaccination site matters for immune response

Science Daily: Pharmacology News

Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same arm.

article thumbnail

Microarray patches safe and effective for vaccinating children, trial suggests

Science Daily: Pharmacology News

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses.

Vaccine 299
article thumbnail

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies

Science Daily: Pharmacology News

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven't worked -- largely because HIV mutates rapidly and hides key parts of itself from the immune system.

Vaccine 270
article thumbnail

Cancer vaccine shows promise for patients with stage III and IV kidney cancer

Science Daily: Pharmacology News

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

Vaccine 245
article thumbnail

Scientists design workaround that improves response to flu vaccine

Science Daily: Pharmacology News

Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them, scientists have shown.

Vaccine 220